Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$2.61
+6.5%
$3.73
$2.18
$8.99
$26.74M0.7220,470 shs290,687 shs
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.33
-14.8%
$0.37
$0.25
$1.28
$17.03M1.19165,330 shs4.12 million shs
Marpai, Inc. stock logo
MRAI
Marpai
$1.35
+2.3%
$1.01
$0.40
$2.25
$20.11M4.7419,208 shs17,773 shs
Ontrak, Inc. stock logo
OTRK
Ontrak
$1.72
+3.9%
$1.51
$1.27
$5.53
$7.27M2.3452,525 shs43,517 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
+6.53%+12.50%-10.31%-57.49%-67.31%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00%0.00%-5.80%-35.64%-70.18%
Marpai, Inc. stock logo
MRAI
Marpai
+2.27%+26.17%+35.00%+46.74%-38.91%
Ontrak, Inc. stock logo
OTRK
Ontrak
+3.86%+12.75%+3.86%+19.72%-61.43%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1.2004 of 5 stars
0.03.00.00.03.81.70.6
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.4734 of 5 stars
0.03.01.70.00.00.80.6
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
3.318 of 5 stars
3.55.00.00.03.80.01.3
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
0.00
N/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
0.00
N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
0.00
N/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
3.00
Buy$45.002,510.21% Upside

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
$515.82M0.05N/AN/A$10.56 per share0.25
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$29.09M0.59N/AN/A$1.09 per share0.30
Marpai, Inc. stock logo
MRAI
Marpai
$34.87M0.58N/AN/A($1.72) per share-0.78
Ontrak, Inc. stock logo
OTRK
Ontrak
$10.85M0.67N/AN/A$5.56 per share0.31
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$92.07M-$1.88N/AN/A-83.50%-60.68%-42.30%5/26/2025 (Estimated)
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
-$26.08MN/A0.00N/A-75.34%-7.96%-5.49%6/12/2025 (Estimated)
Marpai, Inc. stock logo
MRAI
Marpai
-$28.75M-$2.07N/AN/A-85.70%N/A-100.23%N/A
Ontrak, Inc. stock logo
OTRK
Ontrak
-$27.92M-$15.81N/AN/AN/A-237.77%-171.34%-113.42%N/A

Latest OTRK, BNR, MRAI, and ENZ Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
4/14/2025Q4 2024
Ontrak, Inc. stock logo
OTRK
Ontrak
-$1.35-$9.54-$8.19-$9.54$3.08 million$3.08 million
3/25/2025Q4 2024
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
-$1.3970-$1.08+$0.3170-$1.08N/A$17.27 million
3/17/2025Q2 2025
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A-$0.02N/A-$0.03N/A$7.33 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/AN/AN/AN/AN/A
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
$0.40123.08%N/AN/AN/A
Marpai, Inc. stock logo
MRAI
Marpai
N/AN/AN/AN/AN/A
Ontrak, Inc. stock logo
OTRK
Ontrak
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
N/A
3.04
2.78
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
N/A
2.55
2.28
Marpai, Inc. stock logo
MRAI
Marpai
N/A
0.82
0.82
Ontrak, Inc. stock logo
OTRK
Ontrak
0.19
1.17
1.17

Institutional Ownership

CompanyInstitutional Ownership
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.03%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
36.90%
Marpai, Inc. stock logo
MRAI
Marpai
49.75%
Ontrak, Inc. stock logo
OTRK
Ontrak
12.95%

Insider Ownership

CompanyInsider Ownership
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
30.30%
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
11.40%
Marpai, Inc. stock logo
MRAI
Marpai
61.30%
Ontrak, Inc. stock logo
OTRK
Ontrak
1.90%
CompanyEmployeesShares OutstandingFree FloatOptionable
Burning Rock Biotech Limited stock logo
BNR
Burning Rock Biotech
1,39010.24 million7.14 millionNot Optionable
Enzo Biochem, Inc. stock logo
ENZ
Enzo Biochem
52052.40 million46.29 millionOptionable
Marpai, Inc. stock logo
MRAI
Marpai
15014.90 million5.61 millionNo Data
Ontrak, Inc. stock logo
OTRK
Ontrak
2504.22 million4.14 millionNo Data

Recent News About These Companies

Ontrak reports Q4 EPS ($9.29) vs. ($4.02) last year
Ontrak secures Medicaid provider designation in two new states
ONTRAK INC. DL -,0001 (HY10.DU)
Ontrak Inc (HY10.MU)
Ontrak Inc. (HY10.SG)
Ontrak, Inc. Announces Reverse Stock Split
Ontrak, Inc. Announces Reverse Stock Split

New MarketBeat Followers Over Time

Media Sentiment Over Time

Burning Rock Biotech stock logo

Burning Rock Biotech NASDAQ:BNR

$2.61 +0.16 (+6.53%)
As of 05/14/2025 04:00 PM Eastern

Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.

Enzo Biochem stock logo

Enzo Biochem NYSE:ENZ

$0.32 -0.06 (-14.83%)
Closing price 04/17/2025
Extended Trading
$0.32 0.00 (0.00%)
As of 04/17/2025 05:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Enzo Biochem, Inc. develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis. It also provides AMPIVIEW in situ hybridization probes for enhanced detection of low expressed targets useful in the growing spatial biology space; reagents and assays for cell and gene therapy research and development; POLYVIEW PLUS Enhanced Immunohistochemistry platform, offers solutions within the area of anatomical pathology through optimized assays; Enhanced Immunoassays, pushing sensitivity to expand immunoassay applications for basic research, bioprocess, and diagnostics; AMPIPROBE, a nucleic acid amplification platform; and Axxora.com, a proven distribution platform for original manufacturers of innovative research reagents. The company's proprietary products and technologies in translational research and drug development areas, including cell biology, genomics, assays, immunohistochemistry, and small molecule chemistry. It markets its products and services through its direct sales force and a network of distributors. The company was incorporated in 1976 and is headquartered in Farmingdale, New York.

Marpai stock logo

Marpai NASDAQ:MRAI

$1.35 +0.03 (+2.27%)
As of 05/14/2025 03:52 PM Eastern

Marpai, Inc., a technology-driven healthcare payer, focuses on providing services to the self-insured employer market in the United States and Israel. The company offers ancillary services, such as care management, case management, actuarial services, bill review and cost containment services. Marpai, Inc. was incorporated in 2021 and is based in Tampa, Florida.

Ontrak stock logo

Ontrak NASDAQ:OTRK

$1.72 +0.06 (+3.86%)
As of 05/14/2025 03:59 PM Eastern

Ontrak, Inc. operates as an artificial intelligence powered, telehealth-enabled, and virtualized healthcare company that provides in-person services to third-party payors in the United States. Its technology-enabled platform predicts people whose chronic disease will improve with behavior change, recommends effective care pathways that people are willing to follow, and engages and guides them to and through the care they need. The company's technology enabled OnTrak program provides healthcare solutions to members with behavioral conditions that cause or exacerbate chronic medical conditions, such as diabetes, hypertension, coronary artery disease, chronic obstructive pulmonary disease, and congestive heart failure. The OnTrak integrates evidence-based psychosocial and medical interventions delivered in-person or via telehealth along with care coaching and in-market community care coordinators, who address the social and environmental determinants of health. The company was formerly known as Catasys, Inc. and changed its name to Ontrak, Inc. in July 2020. Ontrak, Inc. was incorporated in 2003 and is headquartered in Miami, Florida.